SEQENS

SEQENS positions itself as a global leader in pharmaceutical solutions and specialty ingredients, reflected in its slogan, "Our science for your future." Founded in 2003 and based in France, the company operates 16 manufacturing plants and 9 R&D centers across Europe, North America, and Asia. With a workforce of 3,300, including 350 scientists and experts, SEQENS is committed to delivering customized solutions for its clientele.

The company boasts a diverse portfolio that includes active ingredients, pharmaceutical intermediates, and specialty ingredients. It excels at developing complex molecules by leveraging cutting-edge technologies and innovative approaches. SEQENS reported a revenue of 1 MM€, highlighting its robust market presence.

The last noted investment was a Private Equity Round on 22 June 2016, led by Mérieux Equity Partners. As a key player in the Biotechnology and Pharmaceutical industries, SEQENS offers potential investors a well-established foothold in a high-demand sector.